According to Cassava Sciences
's latest financial reports the company has $0.12 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.12 B | -39.74% |
2022-12-31 | $0.20 B | -13.89% |
2021-12-31 | $0.23 B | 149.65% |
2020-12-31 | $93.5 M | 305.12% |
2019-12-31 | $23.08 M | 16.53% |
2018-12-31 | $19.8 M | 89.02% |
2017-12-31 | $10.47 M | -44% |
2016-12-31 | $18.71 M | -40.21% |
2015-12-31 | $31.29 M | -22.89% |
2014-12-31 | $40.59 M | -18.56% |
2013-12-31 | $49.83 M | -11.41% |
2012-12-31 | $56.25 M | -42.67% |
2011-12-31 | $98.13 M | 7.57% |
2010-12-31 | $91.22 M | -48.1% |
2009-12-31 | $0.17 B | -7.54% |
2008-12-31 | $0.19 B | -7.3% |
2007-12-31 | $0.20 B | 0.33% |
2006-12-31 | $0.20 B | -3.88% |
2005-12-31 | $0.21 B | 113.94% |
2004-12-31 | $99.39 M | 726.45% |
2003-12-31 | $12.02 M | -75.99% |
2002-12-31 | $50.09 M | -23.26% |
2001-12-31 | $65.27 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | 71.86% | ๐บ๐ธ USA |